This message was sent to ##Email##
|
|
|
|
|
AST
Join us for an interactive discussion on personalized medicine at the 2019 Cutting Edge of Transplantation (CEoT) meeting in Phoenix, AZ. There are two great options for housing, but the deadlines are approaching!
READ MORE
AST
Like most non-profit organizations, the AST has many valuable relationships that contribute to its continued growth and sustainability. To give our partners the opportunity to showcase their current initiatives and news, the AST has created its brand-new Partner's Blog.
READ MORE
AST
The AST and ASTS seek candidates for the position of Editor in Chief of the American Journal of Transplantation (AJT). AJT is a monthly, peer reviewed journal dedicated to advancing the science and practice of organ transplantation worldwide by reporting novel and rigorous research. Candidates should possess broad knowledge and experience of organ transplantation and have a distinguished record of scholarly achievement in addition to demonstrated leadership qualities, intellectual vision, outstanding organizational skills, and experience relevant to editing a leading scientific medical journal. The five-year compensated term will start no later than Aug. 1, 2020.
READ MORE
 |
|
The Thompson Liver / Oncology System provides surgeons with the ability to obtain stable, versatile retraction for liver transplants, liver resections, oncology, and obesity cases. Multi-planed retraction and unlimited flexibility for the most complex abdominal and pelvic cases. Call 1-800-227-7543 to start your free trial.
|
|
AST
The AST sponsors a variety of Achievement Awards in recognition of AST members' achievements and contributions to the field of transplantation. The AST encourages members to nominate deserving candidates for consideration. Make your nominations by January 31.
READ MORE
AST
The Fellow of the American Society of Transplantation (FAST) designation application is now open to all members who meet the eligibility criteria. Instructions for the application can be found here. The deadline to apply is January 15, 2019. Don't miss out on joining this prestigious program and be recognized for your contributions to transplantation.
|
The first and only clinically and analytically validated blood test that measures donor-derived cell-free DNA (dd-cfDNA), a direct indicator of kidney injury
Covered by Medicare
AlloSure 101 – Development & Summary Webinar – view
|
|
|
|
|
Reach Your Prospects Every Week
Thousands of industry professionals subscribe to association news briefs, which allows your company to push messaging directly to their inboxes and take advantage of the association's brand affinity.
Connect with Highly Defined Buyers and Maximize Your Brand Exposure
|
|
|
|
|
AST
As an AST member, access to free or discounted educational resources are included in your membership. These diverse educational resources offer materials relevant to the transplant professional in every stage of their career – from basic trainee lessons to webinars on specialized topics. LEARN MORE
AST
Comprehensive Trainee Curriculum (CTC) is a great way to expand your transplant knowledge. This feature is an online educational platform that features dozens of webinars on various concentrations of transplantation.
READ MORE
| Upcoming Education Events
|
    |
AST
Optimizing Informed Consent Processes to Educate Donor and Recipient Candidates about Psychosocial Risks
January 16, 2019 | 2 pm ET | Online Activity
For more information, click here.
Which Live Donor Kidney is Better?
February 20, 2019 | 2 pm ET | Online Activity
For more information, click here.
AST
The Thomas E. Starzl Transplantation Institute is accepting nominations for the 2020 Thomas E. Starzl Prize in Surgery and Immunology, awarded annually to a national or international leader in the field of organ transplantation and immunology. The prize consists of a crystal award, an honorarium of $10,000, and travel expenses to the University of Pittsburgh School of Medicine in the spring of 2020 to formally receive the award and to present the Thomas E. Starzl Prize in Surgery and Immunology lecture. The winner will also participate in related activities and meet informally with faculty, post-doctoral fellows and students.
READ MORE
American Board of Internal Medicine
Registration is now open for all 2019 Maintenance of Certification (MOC) assessments. This is especially important for some of the specialties that have short registration windows for the spring assessments. To check for information on your discipline, click here. If you would like to become re-certified in 2019 by way of the shorter Knowledge Check-In (KCI) assessment, click here.
READ MORE
|
The articles included in this email are for informational use only and are not endorsed by the AST.
|
American Journal of Transplantation
With the aim of consolidating recommendations about the practice of initiating or continuing Intensive Care measures to facilitate Organ Donation (ICOD), an ad hoc working group was established, comprised of 10 intensivists designated by the Spanish Society of Intensive Care and Coronary Units (SEMICYUC) and the Spanish National Transplant Organization (ONT).
READ MORE
American Journal of Transplantation
Livers from older donors (OLD; age greater than or equal to 70) are risky and often declined; however, it is likely that some candidates will benefit from OLDs versus waiting for younger ones. To characterize the survival benefit of accepting OLD grafts, we used 2009‐2017 SRTR data to identify 24,431 adult liver transplant (LT) candidates who were offered OLD grafts eventually accepted by someone.
READ MORE
Liver Transplantation
Early everolimus introduction and tacrolimus minimization after liver transplantation may represent a novel immunosuppressant approach. This phase 2, multicenter, randomized, open‐label trial evaluated safety and efficacy of early everolimus initiation. Patients treated with corticosteroids, tacrolimus, and basiliximab, were randomized (2:1) to receive everolimus (1.5 mg bid) in day 8 and gradually minimize or withdraw tacrolimus when everolimus was stable greater than 5 ng/mL, or to continue tacrolimus at 6‐12 ng/mL.
READ MORE
Gastroenterology
Liver transplantation for patients with acute on chronic liver failure with 3 or more failing organs (ACLF-3) is controversial. We compared liver waitlist mortality or removal according to model for end-stage liver disease (MELD) score vs ACLF category. We also studied factors associated with reduced odds of survival for 1 year after liver transplantation in patients with ACLF-3.
READ MORE
The Journal of Heart and Lung Transplantation
The Canadian status 4S category prioritizes highly sensitized patients with a calculated panel reactive antibody (CPRA) greater than 80 percent awaiting heart transplantation. We examined the impact of sensitization and status 4S and developed a predictive model to estimate waiting time in Canada.
READ MORE
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
